Grant: Dissemination Events - Priority Announcement: Cancer Research
McGill University
$18,280.00
Montreal DNA Tumour Virus Meeting 2012
EF 2011-12
Résumé
In the current proposal we are seeking CIHR support towards the organization of the Montreal DNA Tumour Virus (DNATV) Meeting, which will take place from July 16-21, 2012 at the Centre Mont-Royal in downtown Montreal. This meeting brings together a diverse group of researchers with common research interests in the study of the small DNA tumor viruses. These viruses include the polyomaviruses, the adenoviruses and the papillomaviruses. These viruses have served as invaluable models towards understanding the process of cancer progression. In some cases the DNA tumour viruses are also clinically important pathogens that cause cancer in humans. The most notable examples are the human papillomavirus (HPV) that are the cause of essentially all cervical cancers. The significance of this finding was recognized in 2008 with the awarding of the Nobel Prize in Physiology or Medicine to Harold zur Hausen, the discoverer of the relationship between HPV and cervical cancer. The DNATV meeting has occurred yearly for over 4 decades and over the years has included some of the most significant breakthroughs in biological research. This marks the first time in its history that this meeting is taking place in Canada and represents a landmark opportunity to showcase Canadian research in this topic. Attendance at the meeting is expected to be from 200-250 based upon previous years. During the DNATV meeting in 2011 in Trieste, Italy, 250 scientists from 20 different countries attended. This yearly meeting brings together the DNA tumour virus research community from across the globe and highlights the year's most outstanding research accomplishments in the field. In conjunction with the meeting a public forum will take place in which members of the general public can interact with tumor virus researchers to obtain first hand knowledge concerning health related issues with tumor viruses such as the safety and efficacy of HPV vaccines and the role of viruses in the genesis of human cancer.
Programme
Dissemination Events - Priority Announcement: Cancer Research
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
245945
Name
Branton Philip E
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Dissemination Events Grants
Projecttitle
Montreal DNA Tumour Virus Meeting 2012
Programtype2
Miscellaneous Programs
Orgnameinp2
McGill University
Cihramount2
$18,280
Cihrequipment2
$0
Programname2
Dissemination Events - Priority Announcement: Cancer Research
Keyworddelim
Adenovirus; Cancer; Dna Tumour Viruses; Papillomavirus; Polyomavirus
Abstract
In the current proposal we are seeking CIHR support towards the organization of the Montreal DNA Tumour Virus (DNATV) Meeting, which will take place from July 16-21, 2012 at the Centre Mont-Royal in downtown Montreal. This meeting brings together a diverse group of researchers with common research interests in the study of the small DNA tumor viruses. These viruses include the polyomaviruses, the adenoviruses and the papillomaviruses. These viruses have served as invaluable models towards understanding the process of cancer progression. In some cases the DNA tumour viruses are also clinically important pathogens that cause cancer in humans. The most notable examples are the human papillomavirus (HPV) that are the cause of essentially all cervical cancers. The significance of this finding was recognized in 2008 with the awarding of the Nobel Prize in Physiology or Medicine to Harold zur Hausen, the discoverer of the relationship between HPV and cervical cancer. The DNATV meeting has occurred yearly for over 4 decades and over the years has included some of the most significant breakthroughs in biological research. This marks the first time in its history that this meeting is taking place in Canada and represents a landmark opportunity to showcase Canadian research in this topic. Attendance at the meeting is expected to be from 200-250 based upon previous years. During the DNATV meeting in 2011 in Trieste, Italy, 250 scientists from 20 different countries attended. This yearly meeting brings together the DNA tumour virus research community from across the globe and highlights the year's most outstanding research accomplishments in the field. In conjunction with the meeting a public forum will take place in which members of the general public can interact with tumor virus researchers to obtain first hand knowledge concerning health related issues with tumor viruses such as the safety and efficacy of HPV vaccines and the role of viruses in the genesis of human cancer.
Competitiondate
201110
Approvedterm2
1 yr 0 mth
Pinamesdelim
Branton, Philip E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $18,280~ $0~